Webinar On-Demand: Shift the Paradigm to Centrifuge-less Immuno-staining of Cells for Superior Viability, Recovery & Data

Curiox Biosystems Inc., Announces Initial Public Offering (IPO)

Curiox Biosystems Inc., Announces Initial Public Offering (IPO) August 14th, 2023 SEOUL, SOUTH KOREA, Aug. 14, 2023 /PRNewswire/ — Curiox Biosystems Inc., a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis, announced today the pricing of its initial public offering of 1,400,000 shares of its common stock at a […]